Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the ... of the Chinese Academy of Sciences identified a novel mechanism in understanding the therapeutic mechanism ...

In conclusion, this study developed a novel cyclic peptide antagonist that targets intestinal FXR and disrupts FXR-co-activator interactions, serving as a promising therapeutic approach for MASH ...